Literature DB >> 4853669

Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method.

J M Kinkade, W R Vogler, P G Dayton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853669     DOI： 10.1016/0006-2944(74)90037-4

Source DB:  PubMed          Journal:  Biochem Med        ISSN： 0006-2944


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

2.  Pharmacokinetics of high-dose methotrexate treatment in children.

Authors:  D Bratlid; P J Moe
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

3.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

4.  Clinical pharmacology of intermediate-dose oral methotrexate.

Authors:  D K Smith; G A Omura; F Ostroy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Development and application of a radioimmunoassay for methotrexate.

Authors:  G W Aherne; E M Piall; V Marks
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.